Sound Prescribing Study - Assessing the Impact of Pharmaceutical Marketing and Promotional Practices on Physician Prescribing
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Lumbosacral Muscle Strain
- Sponsor
- American Medical Association
- Enrollment
- 133
- Locations
- 4
- Primary Endpoint
- Decision to prescribe celecoxib
- Status
- Completed
- Last Updated
- 16 years ago
Overview
Brief Summary
The purpose of this study is to determine whether physicians can be educated to better handle inappropriate requests from patients for direct-to-consumer advertised prescription medications.
Detailed Description
Since changes in FDA regulation direct-to-consumer advertising (DTCA), pharmaceutical companies have expended increasing resources to market their products to the public. This has led to increased awareness of diseases and potential treatments, but it has also created more public demand for medications that may not be appropriate for a patient's clinical presentation. This study aims to provide physicians with the knowledge and skills required to help them address inappropriate DTCA medication requests from patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Resident physicians in internal medicine or family medicine specialties at participating study sites
Exclusion Criteria
- •Completed less than 10 months of residency
Outcomes
Primary Outcomes
Decision to prescribe celecoxib